Cheng, Lan
Fu, Qianyu
Zhou, Longhua
Fan, Yuqin
Liu, Fenfen
Fan, Yuanyuan
Zhang, Xin
Lin, Weiqing
Wu, Xiaohe
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms
https://doi.org/10.1038/s41598-022-07395-x
Funding for this research was provided by:
Health Commission of Jiangxi Province (202130028)
Article History
Received: 25 September 2021
Accepted: 16 February 2022
First Online: 3 March 2022
Competing interests
: The authors declare no competing interests.